KT 14480

an NSAID; structure in first source

Also Known As:

KT-14480; KT14480

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Ock, Jiyeon: 1 article (02/2010)
2.	Suk, Kyoungho: 1 article (02/2010)

1.	Necrosis 02/01/2010 - "KT-14480 also suppressed the secretion and expression of several inflammatory mediators such as tumour necrosis factor-alpha, interleukin-1beta and inducible nitric oxide synthase. "
2.	Neuroinflammatory Diseases 02/01/2010 - "Our results indicate that the anti-inflammatory compound KT-14480 may be a novel therapeutic drug candidate against neuroinflammatory diseases."

1.	Interleukin-1beta (Interleukin 1 beta)
2.	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)